MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

VolitionRX Ltd

Suletud

0.47

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.46

Max

0.47

Põhinäitajad

By Trading Economics

Sissetulek

-36K

-5.9M

Müük

-283K

192K

Aktsiakasum

-0.06

Kasumimarginaal

-3,056.099

Töötajad

85

EBITDA

34K

-5.4M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+410.2% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

12. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-7.7M

47M

Eelmine avamishind

0.47

Eelmine sulgemishind

0.47

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. apr 2025, 23:55 UTC

Market Talk

Oil Edges Higher Amid Hopes for Easing U.S.-China Trade Tensions -- Market Talk

27. apr 2025, 23:47 UTC

Market Talk

Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions -- Market Talk

27. apr 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Fears About U.S.-China Tensions Ebb -- Market Talk

27. apr 2025, 23:12 UTC

Tulu

Sinopharm Group 1Q Rev CNY141.66B Vs. CNY147.27B >1099.HK

27. apr 2025, 23:12 UTC

Tulu

Sinopharm Group 1Q Net CNY1.46B Vs. Net CNY1.42B >1099.HK

27. apr 2025, 20:41 UTC

Tulu

Pharmaron Beijing 1Q Net CNY305.58M Vs. Net CNY230.56M >300759.SZ

27. apr 2025, 20:41 UTC

Tulu

Pharmaron Beijing: Higher Contributions From Laboratory Services Among Factors Supporting Results> 300759.SZ

27. apr 2025, 20:41 UTC

Tulu

Pharmaron Beijing 1Q Rev CNY3.10B Vs. CNY2.67B >300759.SZ

27. apr 2025, 18:41 UTC

Peamised uudised

Bessent Doesn't Know If Trump and Xi Have Talked on Trade -- Barrons.com

27. apr 2025, 11:00 UTC

Peamised uudised

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks -- Heard on the Street -- WSJ

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank 1Q Net CNY12.46B Vs. Net CNY12.43B >601818.SH

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank: Lower Net Interest Income Weighed on Operating Income>601818.SH

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank 1Q Operating Income CNY33.10B Vs. CNY34.49B>601818.SH

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank 1Q Impairment Loss on Credit Assets Was CNY8.49B; Down 15.6% on Year>601818.SH

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank 1Q Operating Expenses Was CNY9.15B; Down 3.2%>601818.SH

27. apr 2025, 05:41 UTC

Tulu

China Everbright Bank 1Q Net Interst Income Was CNY22.54B; Down 6.8% on Year>601818.SH

27. apr 2025, 05:34 UTC

Tulu

Chongqing Rural Commercial Bank: 1Q Results Supported by Higher Net Interest Income>3618.HK

27. apr 2025, 05:34 UTC

Tulu

Chongqing Rural Commercial Bank 1Q Operating Income CNY7.22B Vs. CNY7.13B>3618.HK

27. apr 2025, 05:34 UTC

Tulu

Chongqing Rural Commercial Bank 1Q Net CNY3.75B Vs. Net CNY3.52B >3618.HK

27. apr 2025, 05:29 UTC

Tulu

China Shenhua Energy: Results Weighed by Fall in Selling Prices of Coal >1088.HK

27. apr 2025, 05:29 UTC

Tulu

China Shenhua Energy 1Q Net CNY13.37B Vs. Net CNY17.76B >1088.HK

27. apr 2025, 05:29 UTC

Tulu

China Shenhua Energy 1Q Rev CNY69.59B Vs. CNY87.65B >1088.HK

27. apr 2025, 05:29 UTC

Tulu

China Shenhua Energy: Lower Revenue From Electricity Sales Also Hurt Results >1088.HK

27. apr 2025, 05:21 UTC

Tulu

CMOC Group 1Q Net CNY3.95B Vs. Net CNY2.07B >3993.HK

27. apr 2025, 05:21 UTC

Tulu

CMOC Group: Cost Cuts Also Among Factors that Boosted 1Q Net >3993.HK

27. apr 2025, 05:21 UTC

Tulu

CMOC Group 1Q Rev CNY46.01B Vs. CNY46.12B >3993.HK

27. apr 2025, 05:21 UTC

Tulu

CMOC Group: Increase in Prices of Copper, Cobalt Supported Results>3993.HK

27. apr 2025, 03:00 UTC

Peamised uudised

Chinese Manufacturers Are Scouring the World for New Buyers -- WSJ

27. apr 2025, 00:30 UTC

Peamised uudised

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ

27. apr 2025, 00:30 UTC

Peamised uudised

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ -2-

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

410.2% tõus

12 kuu keskmine prognoos

Keskmine 2.5 USD  410.2%

Kõrge 2.5 USD

Madal 2.5 USD

Põhineb 2 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.